The Court appointed MMM+B as counsel to work on behalf of thousands of investors in Cardinal Health. The Complaint in this securities class action alleges that Cardinal, and certain of its officers and directors issued materially false statements concerning the Company's financial condition. Specifically, defendants failed to disclose: (i) that Cardinal manipulated various aspects of its accounting practices to continuously portray profitability to market; (ii) that Cardinal held inventory for an average of two months, and reaped exorbitant profits from price inflation; (iii) Cardinal improperly accounted for the $22 million recovered from Vitamin makers accused of overcharging Cardinal by booking such recoveries as revenue when the antitrust cases had not been resolved; and (iv) that Cardinal's pharmaceutical distribution business improperly classified revenues by reporting the revenues as either operating revenue or revenues form bulk deliveries to consumer warehouses when revenues were not derived from such.